Clinical Trial Update: Colorectal Omics and OfCS Proteoglycans

View source ↗

Summary

A recruiting clinical trial evaluating colorectal omics and OfCS proteoglycans in colorectal cancer, diverticulitis, and inflammatory bowel diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Diverticulitis
• Inflammatory Bowel Disease

Drugs mentioned

• OfCS proteoglycans

Snippet

Sponsor: Claus Anders Bertelsen, PhD, MD | Conditions: Colorectal Cancer, Diverticulitis, Colonic | Status: RECRUITING